SA
PBLS logo
Parabilis Medicines, Inc.(PBLS)
Closing price · checked 12:11 PM ETAbout this dataData status
$27.39▼-1.08 (-3.79%)
After Hours:$28.99+1.60 (+5.84%)· 12:11 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 28.6 · elevated volatility

Overview →

Parabilis Medicines, Inc. (PBLS)

Operating Income

-$189.60M

TTM · Period ending: · USD

PBLS logo

PBLS Operating Income

Latest reported-$189.60M
PBLS Operating Income (-$126.13M → -$189.60M)
High-resolution chart · PNG

What is operating income?

Operating income is profit from the core business after operating costs, before interest and income taxes.

Compare operating income

PBLS operating income history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Parabilis Medicines, Inc. Operating Income — Annual fiscal periods (USD)
Period endingOperating Income (USD)
-152,079,000
-126,125,000

Frequently asked questions: PBLS operating income

What is Parabilis Medicines, Inc. (PBLS)'s current operating income?

Parabilis Medicines, Inc. (PBLS)'s latest reported operating income (TTM) is -$189.60M as of Sep 30, 2026. Operating income is profit from the core business after operating costs, before interest and income taxes.

How much historical operating income data is available for PBLS?

Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s operating income, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare PBLS's operating income to peers or set an alert?

You can compare PBLS's operating income directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on PBLS delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.